1. Aune D. Plant Foods, antioxidant biomarkers, and the risk of cardiovascular disease, cancer, and mortality: A review of the evidence. Advances in Nutrition. 2019;10(4):S404-21. [
Crossref]
2. Wilson L, Bhatnagar P, Townsend N. Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983-2013: joinpoint regression analysis. Population health metrics. 2017;15(1):23. [
Crossref]
3. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International journal of cancer. 2019;144(8):1941-53. [
Crossref]
4. Farhood B, Raei B, Malekzadeh R, Shirvani M, Najafi M, Mortezazadeh T. A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries. Contemporary Oncology. 2019; 23(1): 7. [
Crossref]
5. Christou N, Perraud A, Blondy S, Jauberteau MO, Battu S, Mathonnet M. E cadherin: A potential biomarker of colorectal cancer prognosis. Oncology letters. 2017;13(6): 4571-6. [
Crossref]
6. Enayatrad M, Etemad K, Khodakarim S, Yavari P. Investigating the relationship between the incidence of colorectal cancer and human development index in Iran: An ecological study. Iran J Epidemiol. 2017; 13 (3): 244- 52. [In Persian]
7. Maughan TS, James RD, Kerr DJ, Ledermann JA, McArdle C, Seymour MT, Cohen D, Hopwood P, Johnston C, Stephens RJ. Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. The Lancet. 2002; 359(9317): 1555-63. [
Crossref]
8. Bahrami M, Assarroudi M, Mahmoodzadeh M. Investigation of Symptoms'Frequency, Severity, and Distress in Patients with Leukemia Admitted to Hematology-Oncology Wards of Selected Hospitals in Isfahan, Iran, in 2016. J Health System Res. 2017; 13(2): 140- 45. [In Persian]
9. Van de Poll-Franse LV, Haak HR, Coebergh JW, Janssen-Heijnen ML, Lemmens VE. Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia. 2012 Aug 1;55(8):2163-72. [
Crossref]
10. Pashaeypoor S, Sayadi L, Khosroparviz K. Primary Immunodeficiency Diseases. .2017
11. Prager GW, Braga S, Bystricky B, et al. Global cancer control: responding to the growing burden, rising costs and inequalities in access. ESMO Open. 2018; 3(2). [
Crossref]
12. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. European J Cancer. 1994; 30(9): 1326- 36. [
Crossref]
13. Naseri N, Taleghani F. Depression in cancer patients: the role of demographic variables. Iran J Cancer Nurs. 2019; 1(1): 55- 61. [In Persian] [
Crossref]
14. Naseri N, Taleghani F. Social support and depression in Iranian cancer patients: the role of demographic variables. J caring sci. 2018; 7(3): 143- 47. [
Crossref]
15. Hann DM, Oxman TE, Ahles TA, Furstenberg CT, Stuke TA. Social support adequacy and depression in older patients with metastatic cancer. Psycho‐Oncology. 1995; 4(3): 213- 21. [
Crossref]
16. Tan M, Karabulutlu E. Social support and hopelessness in Turkish patients with cancer. Cancer nurs. 2005; 28(3): 236- 40. [
Crossref]
17. Rodin G, Walsh A, Zimmermann C, et al. The contribution of attachment security and social support to depressive symptoms in patients with metastatic cancer. Psycho‐Oncology: Journal of the Psychological, Social and Behavioral Dimensions of Cancer. 2007; 16(12): 1080- 91. [
Crossref]
18. Salehi Sh, Tajvidi M, Ghasemi V, Raee Z. Investigating The effect of nurses' supportive and educational care on quality of life of breast cancer patients referred for radiotherapy in Seyed Al-Shohada Hospital in Isfahan 2013. J Clin Nurs Midwifery. 2016; 5(2): 9- 18. [In Persian]
19. Fafouti M, Paparrigopoulos T, Zervas Y, et al. Depression, anxiety and general psychopathology in breast cancer patients: a cross-sectional control study. In Vivo. 2010; 24(5): 803- 10.
20. Pedram M, Mohammadi M, Naziri GH, Aeinparast N. Effectiveness of cognitive-behavioral group therapy on the treatment of anxiety and depression disorders and on raising hope in women with breast cancer. J Woman and Society. 2011; 1(4): 61- 75. [In Persian].